Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,958 total articles

Digital Realty Opens First Asia Pacific Innovation Lab in Japan to Help Accelerate AI and Hybrid Cloud Deployment

Digital Realty Opens First Asia Pacific Innovation Lab in Japan to Help Accelerate AI and Hybrid Cloud Deployment

Digital Realty has opened its first Innovation Lab in the Asia Pacific region at its Tokyo data center through a joint venture with Mitsubishi Corporation. The lab enables customers to test and optimize AI and hybrid cloud architectures under real-world conditions, supporting Japan's accelerated investments in AI and semiconductor technologies. The…

Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer

Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer

Tilray Brands, Inc. introduced PORTAL™, a new premium cannabis brand designed for high-tolerance, experienced consumers, featuring products infused with liquid diamonds and diamond-coated flower, offering exceptional potency and consistency. This launch, targeting the growing vape and infused pre-roll markets in Canada ahead of 4/20, aims to differ…

Exodus Movement, Inc. March 2026 Treasury Update and Monthly Metrics

Exodus Movement, Inc. March 2026 Treasury Update and Monthly Metrics

Exodus Movement, Inc., a self-custodial cryptocurrency platform, reported growth in its digital asset treasury holdings and ongoing development of its payments infrastructure for March 2026, despite a notable decrease in overall crypto trading volumes industry-wide. Monthly active users and swap volumes declined slightly compared to February, refle…

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas

Plus Therapeutics, Inc. announced that the U.S. FDA has granted Orphan Drug Designation (ODD) to its targeted radiotherapeutic agent REYOBIQ™ for pediatric malignant gliomas, including pediatric ependymoma. This designation offers potential market exclusivity and incentives, supporting the company's ongoing development efforts in CNS cancers with l…

Rocket Lab Completes at the Market Offering

Rocket Lab Completes at the Market Offering

Rocket Lab Corporation has completed its at-the-market equity offering program, selling approximately 6.7 million shares and raising about $474 million in gross proceeds. The company also entered into collared forward transactions involving additional shares with expected proceeds ranging from $474 million to $642 million, maturing in April 2028. T…

PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy

PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy

PMGC Holdings Inc. (NASDAQ: ELAB) has fully utilized its $20 million equity financing facility, strengthening its cash position to support ongoing and future acquisitions. The company's recent acquisitions span precision CNC manufacturing and specialty IT packaging sectors servicing aerospace, defense, medical devices, semiconductor, and data cente…

Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14

Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14

Ovid Therapeutics announced a research and development event on April 14, 2026, showcasing their first-in-class potassium-chloride co-transporter 2 (KCC2) activators. The event will feature clinical and translational experts discussing pharmacodynamics, development strategy, and market potential of Ovid’s proprietary molecules targeting neurologica…

Rezolve Ai Goes Directly to Commerce.com Shareholders with Proposal to Create a $700+ Million Global Agentic Commerce Powerhouse

Rezolve Ai Goes Directly to Commerce.com Shareholders with Proposal to Create a $700+ Million Global Agentic Commerce Powerhouse

Rezolve Ai PLC, a Nasdaq-listed company, has issued an open letter to Commerce.com Inc. shareholders proposing a direct acquisition offer after Commerce.com's board rejected engagement. The all-stock deal offers 1 Rezolve share for every 2 Commerce.com shares, aiming to form a $700+ million global AI commerce powerhouse. Rezolve highlights Commerce…

New Era Energy & Digital Closes Multi-Tranche $290 Million Senior Secured Term Loan Credit Facility with Macquarie Group to Finance Texas Critical Data Center Flagship Project

New Era Energy & Digital Closes Multi-Tranche $290 Million Senior Secured Term Loan Credit Facility with Macquarie Group to Finance Texas Critical Data Center Flagship Project

New Era Energy & Digital, a Nasdaq-listed developer of next-generation digital infrastructure, announced a $290 million senior secured term loan credit facility with Macquarie to fund its flagship Texas Critical Data Center project. The multi-tranche financing supports acquisition, development, and equipping of the data center campus near Odessa, T…

Collegium to Participate in Upcoming Investor Conferences

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced its management will participate in the 25th Annual Needham Virtual Healthcare Conference and Piper Sandler Spring Biopharma Symposium. The company highlighted its growth strategy centered on its neuropsychiatry business, especially Jornay PM, and plans to grow its commercial portfolio responsi…

Captivision Announces Nasdaq Global Markets Delisting to OTC

Captivision Announces Nasdaq Global Markets Delisting to OTC

Captivision Inc. announced its delisting from the Nasdaq Global Market due to failure to meet financial filing deadlines. The company will begin trading on the OTC Pink Limited tier under the symbol CAPTF. Captivision plans to complete financial audits, file required SEC reports, and proceed with a transformational acquisition of Montana Tunnels Mi…

Hudbay to Host Conference Call for First Quarter 2026 Results

Hudbay to Host Conference Call for First Quarter 2026 Results

Hudbay Minerals Inc., a copper-focused mining company with operations in Canada, Peru, and the U.S., will release its first quarter 2026 financial results on May 1, 2026. The company will host a conference call and webcast to discuss these results. Hudbay’s portfolio includes multiple mines and projects primarily producing copper along with gold, z…

MicroCloud Hologram Inc. State-Based Fully Quantized Imaginary-Time Evolution Simulation Technology Reshapes the Ground State Solving Path

MicroCloud Hologram Inc. State-Based Fully Quantized Imaginary-Time Evolution Simulation Technology Reshapes the Ground State Solving Path

MicroCloud Hologram Inc. has developed an innovative state-based imaginary-time evolution quantum simulation technology that solves the non-unitary evolution challenge in quantum computing. This new method accelerates quantum ground state computations using fully quantum resources, minimizing reliance on classical processing and enabling noise-robu…

Aclarion Announces Agreement with Weill Cornell Medicine

Aclarion Announces Agreement with Weill Cornell Medicine

Aclarion, a Nasdaq-listed healthcare technology company, announced a commercial agreement with Weill Cornell Medicine and NewYork-Presbyterian to implement its Nociscan SaaS platform. This technology helps physicians noninvasively detect painful discs in the lumbar spine using biomarkers and AI algorithms. The partnership will also support a clinic…

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

Kiniksa Pharmaceuticals International has initiated Heart’s Home™, a direct-to-consumer TV and digital campaign to increase awareness of recurrent pericarditis and encourage patients to discuss ARCALYST, the first and only FDA-approved therapy for this condition, with their healthcare providers. The campaign aims to expand the patient base and driv…

Fiverr to Release First Quarter 2026 Results on April 29, 2026

Fiverr to Release First Quarter 2026 Results on April 29, 2026

Fiverr International Ltd., a NYSE-listed company revolutionizing digital freelance services, will release its Q1 2026 financial results on April 29, 2026, before market open. Management will host a conference call and webcast to discuss business and financial outcomes, along with a shareholder letter made available on their investor website.

Whitestone REIT Declares Second Quarter 2026 Dividend

Whitestone REIT Declares Second Quarter 2026 Dividend

Whitestone REIT declared a quarterly cash dividend of $0.1425 per share for the second quarter of 2026. The dividend will be paid on June 29, 2026, to shareholders of record as of June 17, 2026. The company is a community-centered real estate investment trust focusing on open-air retail centers in fast-growing US markets such as Phoenix, Austin, Da…